3H]RS79948-197 binding to human, rat, guinea pig and pig alpha2A-, alpha2B- and alpha2C-adrenoceptors. Comparison with MK912, RX821002, rauwolscine and yohimbine

European Journal of Pharmacology
S UhlénJ E Wikberg

Abstract

The Kd values of the recently introduced radioligand [3H]RS79948-197 ((8a R,12aS,13a-S)-5,8,8a,9,10,11,12,12a,13,13a-decahydro-3-metho xy-12-(ethylsulphonyl)-6H-isoquino[2,1-g][1,6]naphthyridine) were determined for the recombinant human and rat alpha2A-, alpha2B- and alpha2C- as well as guinea pig alpha2B- and alpha2c-adrenoceptors expressed in COS (CV-1 Origin, SV40) cells. In addition, the Kd values were also determined for [3H]RS79948-197 for the guinea pig spleen alpha2A-adrenoceptor and for pig alpha2A-, alpha2B- and alpha2C-adrenoceptors in membranes obtained from kidney and striatum. Available radioligands for alpha2-adrenoceptors, besides [3H]RS79948-197 are the tritiated forms of MK912 ((2S,12bS)1',3'-dimethylspiro(1,3,4,5',6,6',7,12b-octa hydro-2H-benzo[b]furo[2,3-a]quinazoline)-2,4'-pyrimidin-2'-one), RX821002 (2-methoxy-idazoxan), rauwolscine and yohimbine. In the present article the binding constants of all these substances for the alpha2A-, alpha2B- and alpha2C-adrenoceptor subtypes in human, pig, rat and guinea pig are reviewed. In all species tested MK912 was alpha2C-selective, RX821002 showed a minor alpha2A-selectivity, whereas [3H]RS79948-197 was non-selective among the alpha2-adrenoceptor subtypes, showing ...Continue Reading

References

Nov 1, 1994·Trends in Pharmacological Sciences·J P Hieble, R A Bond
Nov 1, 1994·Naunyn-Schmiedeberg's Archives of Pharmacology·A U TrendelenburgN Limberger
Jan 1, 1993·Pharmacology & Toxicology·Y XiaJ E Wikberg
Mar 1, 1993·Naunyn-Schmiedeberg's Archives of Pharmacology·S UhlénJ E Wikberg
Mar 1, 1996·Trends in Pharmacological Sciences·R M GrahamK R Lynch
Dec 12, 1996·European Journal of Pharmacology·S P HumeV W Pike
May 30, 1997·Annals of the New York Academy of Sciences·C M MilliganP Towers

❮ Previous
Next ❯

Citations

May 19, 2005·Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology·Jörg R AschenbachG Gäbel
Jun 30, 2001·European Journal of Pharmacology·Y P JarajapuA MacDonald
Dec 2, 1999·Neuroscience and Biobehavioral Reviews·G Flügge
Feb 27, 2007·Nature Medicine·Anastasios LymperopoulosWalter J Koch
May 21, 2003·Journal of Veterinary Pharmacology and Therapeutics·K TörnekeA Neil
Apr 16, 2004·Autonomic & Autacoid Pharmacology·M R CorbozJ A Hey
Oct 21, 2003·Autonomic & Autacoid Pharmacology·M C Koss
Sep 6, 2005·Epilepsy Research·Chris W D JurgensVan A Doze
Dec 9, 2008·Autonomic Neuroscience : Basic & Clinical·Cristiane BusnardoFernando Morgan Aguiar Corrêa
Aug 21, 2002·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·Y-L LiuM J Stock
Jul 10, 2004·Journal of Cardiovascular Pharmacology·Maija DambrovaJarl E S Wikberg
Jun 15, 2007·British Journal of Pharmacology·J M M LaurilaM Scheinin
Apr 1, 2010·Basic & Clinical Pharmacology & Toxicology·Shawquia YoungMałgorzata Dukat
May 12, 2011·British Journal of Pharmacology·K NäreojaJ Näsman
Jan 18, 2008·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Melissa A HermanRichard A Gillis
Apr 21, 2010·The Journal of Pharmacology and Experimental Therapeutics·Tadashi IshibashiMitsutaka Nakamura
Jun 8, 2006·The Journal of Pharmacology and Experimental Therapeutics·Steven C PrinsterRandy A Hall
Jul 15, 2005·Molecular Pharmacology·Jun-Ho LeeSeung-Yeol Nah
Feb 6, 2016·Molecular Endocrinology·Malika JafferjeeAnastasios Lymperopoulos
Apr 6, 2000·American Journal of Physiology. Heart and Circulatory Physiology·M A ChotaniN A Flavahan
Aug 15, 2002·CNS Drug Reviews·R W Clarke, J Harris
Jul 26, 2011·Biological Psychiatry·Rachel J Smith, Gary Aston-Jones
Feb 13, 2001·European Journal of Pharmacology·S P UmlandJ A Hey
Sep 1, 2004·European Journal of Pharmacology·Veronica FagerholmMika Scheinin
Nov 24, 2004·European Journal of Pharmacology·Veronica FagerholmMerja Haaparanta
Mar 27, 2007·Journal of Natural Products·Nai-Kuei HuangYun-Lian Lin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.